Brandon Martell

[Inari, now part of Stryker @InariMedical]

Interim 2-year outcomes from the largest mechanical #thrombectomy study for #DVT: #CLOUT shows patients treated with #ClotTriever saw significant improvement in PTS symptoms. Presented by Dr. David Dexter at #VENOUS2024!

#safety #effectiveness #evidence

[Inari, now part of Stryker @InariMedical]

An 85 y/o female presented with no thrill in her left brachiocephalic #fistula. Dr. Vikingstad used the #InThrill #thrombectomy system to remove #clot & restore AV Access. The patient was sent for #dialysis treatment post-procedure.

Learn more about InThrill for AV #thrombosis:
https://t.co/rzDA0kCcxp

[Inari, now part of Stryker @InariMedical]

We are proud to announce the launch of the new RevCore™ Thrombectomy Catheter, the first mechanical thrombectomy device designed for acute to chronic venous in-stent #thrombosis!

Interested in learning more about #RevCore? Register for the upcoming @VenousSymposium webinar on June 7 for more! https://t.co/5f336Ecsdi

[Inari, now part of Stryker @InariMedical]

As the latest representation of Inari's commitment to clinical evidence, we are proud to share the planned enrollment of the #PEERLESS II trial, a prospective, global, multi-center RCT comparing the outcomes of #PE patients treated with the #FlowTriever system vs #anticoagulation alone: https://t.co/w2ZrIfx5ec

[Inari, now part of Stryker @InariMedical]

The importance of clinical evidence in guiding treatment decisions & advancing patient care cannot be overstated.

Dr. Nicole Ilonzo & Dr. Lorena De Marco cover how #ClotTriever became the most studied thrombectomy device in #DVT care on @EVToday https://t.co/PaAps6uYue

[Endovascular Today @EVToday]

Inari Medical’s FlowTriever System Studied in FLAME Trial for Treatment of High-Risk PE | @InariMedical #ACC23
https://t.co/aDmZySEFIU

[Inari, now part of Stryker @InariMedical]

Presented at #ACC23:

The #FLAME Study reported 1.9% in-hospital mortality in patients treated with #FlowTriever, a >90% reduction compared to the context arm & historical data: https://t.co/zUIlpwjHFU

Register for our upcoming webinar to learn more: https://t.co/taeR9eWW87

[Inari, now part of Stryker @InariMedical]

FLAME: The study designed to generate high-quality evidence for interventional treatments in high-risk PE. Data release coming March 5 at #ACC23!

Register for the post-show webinar here: https://t.co/taeR9eXtXF

#FLAMEStudy #ACC2023 #WCCardio

[Inari, now part of Stryker @InariMedical]

Presented at #VENOUS2023:

New results on the 63 high-risk PE patients in #FLASH presented LIVE by @jameshorowitzmd reinforces the excellent safety and mortality outcomes with the #FlowTriever System

More #PE data coming soon with #FLAME | Mar. 5 at #ACC23

[Adrian Mercado MD, FACC @AdrianMercadoMD]

Lollipopping T24 @InariMedical
< sound on> "I feel better already"

[Keith Pereira MD, #VIrad @keithppereira]

Scarred from the one PE, when you least expected, during a routine DVT thrombectomy?

#Pro-Tip #Pro-Trieve

The confidence to perform 'aggressive' Mechanical thrombectomy/ balloon angioplasty with less fear of Pulmonary embolization. A win-win for all.

#VIrad

[Inari, now part of Stryker @InariMedical]

Upcoming #ClotWarriorAcademy webinar: Outcomes from #FLASH800: The Largest Prospective Registry of #PE

🗓️ Thursday, October 6th, 4 pm PT / 7 pm ET

Register here: https://t.co/iOYseL8AYr

#pulmonaryembolism #VTE

[Inari, now part of Stryker @InariMedical]

Results from the FLASH registry, the largest prospective, interventional registry of #pulmonaryembolism, were presented by @CatalinPToma at #TCT2022.

Read more: https://t.co/U3tEzh4uSF

#FLASH800

[Inari, now part of Stryker @InariMedical]

Check out @EVToday's The Dangers of Leaving #Thrombus Behind. @DrJayMohan and Dr. Maziar Mahjoobi discuss their process to evaluate for concomitant #DVT and present cases that highlight the benefits of routine DVT assessment in #pulmonaryembolism patients: https://t.co/BdLVCf5K74

[Inari, now part of Stryker @InariMedical]

Another manuscript from the #CLOUT registry has been published in @JVascSurg: #Venous and Lymphatic Disorders. Outcomes show symptom duration may underestimate #DVT chronicity.

See the full publication: https://t.co/RFZQffxReS

[Inari, now part of Stryker @InariMedical]

In honor of Mother’s Day, we’re looking back at a special #ClotWarrior story highlighting the perseverance of a young mother and her battle with #DVT.

Wishing mothers around the world a loving and fulfilled #MothersDay.

https://t.co/5BTxryIGnZ

[Dr Chris Huff @hufcm]

(1/2) Interesting case from yesterday. Mechanical thrombectomy in a pt with situs inversus and a saddle PE. Strategy the same. Treat right PA first (on the left side of the body) and catheter will flip into left PA (right side of body) on pullback. #PE #DVT @InariMedical

[Anna Horchmer @Silvio_N_Leal]

First Portuguese use of Flowtriever device in acute pulmonary embolism Great aspirative power, very impressive result.
@Hospital de Santa Cruz, Lisbon
@InariMedical

[Inari, now part of Stryker @InariMedical]

Significant #thrombus removal with the #ClotTriever system result in immediate & sustained benefits for patients with acute to #chronic #DVT. Lytic-free, #mechanicalthrombectomy in a single session.

See these & other results from the #CLOUT registry: https://t.co/tGN4fzxkt2

[Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI @DrJayMohan]

1/ Atypical CLOT- a tweetorial

I recently saw a controversial tweet arguing against tx of chronic clot and restricting tx SOLEY to the CFV/iliac. While I agree (for the most part)- data is limited. At the end of the day we care about the pt, and not every pt is the same! Case➡️